Manhattan Pharmaceuticals, Tarpan Therapeutics Inc. deal

MHTT completed its previously announced stock acquisition of Tarpan. MHTT would not disclose the deal value. When the acquisition was proposed in Jan., it was valued at about $10 million (see BioCentu...